Used as a chemotherapy medicine
Natco Pharma announced today that its marketing partner in the USA, Breckenridge Pharmaceutical, Inc., has filed an Abbreviated New Drug Application (ANDA) for Bendamustine Hydrochloride powder; IV infusion (25mg/vial and 100mg/vial).Teva (Cephalon) sells Bendamustine Hydrochloride under brand name TREANDA, used as a chemotherapy medicine in oncology segment.
The market size of Bendamustine Hydrochloride in the USA is approximately US$660M for twelve months ending September 2013, according to IMS Health.
Powered by Capital Market - Live News
